Life Sciences
Researchers from McGill University, Health Center provide details of new studies and findings in the area of life sciences
Published in Hospital Law Weekly, July 10th, 2008
A new study, 'When temozolomide alone fails: adding procarbazine in salvage therapy of glioma,' is now available. "Since temozolomide (TMZ) entry into routine practice in the first-line management of glial tumors, post-TMZ recurrences present a growing challenge. Without standard chemotherapy for TMZ failure, care in such palliative settings requires consideration not only of efficacy but of toxicity and convenience," investigators in Montreal, Canada report.
"At our institution, a combination regimen has been used: oral alkylating agents procarbazine (PCB) (100-150 mg/m2/day) and TMZ (150-200 mg/m2/day) administered on days 1-5 of a 28-day cycle. This treatment has...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2008-07-10)
More Articles from Hospital Law Weekly
- Ballard Spahr Andrews & Ingersoll, LLP
Ballard Acquires Atlanta IP Group - Business of Birth International
Controversies in Childbirth Conference Draws Broad Interest Across Medical Professions, Across the U.S., and Across the Atlantic - Drug Resistance
Federal Action Needed to Fill Antibiotic Pipeline, Says the Alliance for the Prudent Use of Antibiotics - Eric Drew
Credit Card Companies Fueling Healthcare Associated Identity Theft (HAIT) Crimes - Health Insurance
Potential Blues Merger Poses Concern for Area Health Systems - Heart Disease
Appellate Court Rules That $2.7 Million Heart Transplant Verdict Should Stand - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
